Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats

Figure 1 Effects of berberine on plasma glucose levels in the oral glucose tolerance test and the areas under the curves for plasma glucose. ^bP < 0.01 vs the normal control group at the corresponding time point; ^dP < 0.01 vs the model group at the corresponding time point (by ANOVA). AUC: Areas under the curve.